Brain–Computer Interfaces: When the Brain Connects to a Machine

What is a brain–computer interface?

A brain–computer interface (BCI) is a system that measures activity in the nervous system, extracts a pattern related to an intention or task, and converts it into a command for an external device. In the strict sense, not every neurotechnology and not every sensor placed on the head is a BCI. The defining feature is a functional communication pathway in which neural activity helps control a system without relying on the usual muscular output route.

That distinction matters because the BCI label often carries more marketing than precision. An EEG headband, a brain-stimulation system, an attention monitor, and an implanted cursor-control system are not the same thing. If all of them are called BCI, we lose the distinction between sensing, decoding, stimulation, therapy, and enhancement.

Most current BCIs do not “read thoughts” in the cinematic sense. A decoder is usually trained to associate a limited class of neural patterns with a predefined task: attempting to move a hand, imagining handwriting, attempting speech, or selecting among commands. Performance depends on what is measured, where it is measured, how the system is trained, and the context in which it is used.

That does not make mental privacy irrelevant. On the contrary, as decoders improve, neural data become more valuable. But criticism must remain exact. Current BCIs are not universal scanners of hidden beliefs, memories, and inner monologue. Exaggerating present capabilities can unintentionally assist the same marketing that portrays the technology as nearly supernatural.

BCIs can measure brain activity in very different ways. Non-invasive systems, such as EEG, require no surgery but record through the skull and generally have lower spatial resolution and more noise. Surface or ECoG systems place electrodes on the brain’s surface, while intracortical systems use microelectrodes closer to neuronal populations. Endovascular approaches such as the Stentrode attempt to bring electrodes near the brain through a blood vessel.

More direct access can produce richer signals, but it also carries a greater biological or surgical burden. It is therefore misleading to call a system “more advanced” only because it has more electrodes or higher decoding speed. The better system for a patient is the one that delivers a genuinely better balance of useful function, risk, maintenance, and lifetime usability.

When a BCI gives a person their voice back

Some of the strongest recent progress concerns people who lost speech because of paralysis or neurodegenerative disease. In 2024, an intracortical speech neuroprosthesis in a person with ALS achieved high accuracy after relatively brief initial training and enabled self-paced conversation at about 32 words per minute. In 2025, researchers also demonstrated near-instantaneous voice synthesis from attempted speech, including some control of intonation.

The technology is remarkable, but the moral core is simple: the aim is not to manufacture a “more-than-human” person but to restore that person’s own communication. This is why THY-REALITY does not reject neurotechnology as such. The critical boundary is not “electronics near the brain”; it is purpose, proportionality of risk, and whether technology releases a person from lost function or creates a new dependency that was not medically necessary.

In 2021, an intracortical BCI converted attempted handwriting movements into text for a person with paralysis at roughly 90 characters per minute. The endovascular Stentrode system later enabled four people with severe paralysis to control digital devices; no serious device-related adverse events were reported during 12 months of follow-up, but the analyzed sample contained only four participants.

In March 2026, China approved commercial launch of a minimally invasive BCI medical device for selected people with tetraplegia, intended to help restore grasp control through an external glove. That is an important move from experimental research toward the medical market. It is not evidence that invasive BCIs are already routine, long-term-proven technology for mass use.

Even the most highly publicized implants remain largely in early clinical stages. Neuralink’s PRIME study is listed on ClinicalTrials.gov as a first-in-human early feasibility study evaluating initial safety and device functionality in people with tetraparesis or tetraplegia; the U.S. study involves a small planned cohort and years of follow-up. Synchron programs likewise remain clinical studies or early medical programs for people with severe motor impairment.

A sharp line is therefore needed between a prototype demonstration and a social vision of mass brain–computer integration. Showing that something can work in a selected patient under controlled conditions is not the same as establishing long-term safety, effectiveness, reparability, and acceptability for millions of healthy people.

What is actually being decoded?

A BCI decoder does not plug into an abstract stream of “thought.” It maps statistical patterns in recorded signals. In motor BCIs those patterns may correspond to attempted movement; in speech BCIs to articulatory or language-related activity; in EEG systems to characteristic responses to stimuli. The user and the algorithm often learn each other: the person adapts strategy while the system adapts decoding parameters.

This co-adaptive nature is central to understanding the achievements. If a system can recognize attempted speech after hours or days of calibration, that is not equivalent to a device that can read an arbitrary sentence from an unknown person without cooperation. For every BCI claim, ask: what was the task, what training was required, what signal was used, and what alternatives were available to the decoder?

A widely discussed 2023 study used fMRI to reconstruct semantic approximations of continuous language that participants heard or imagined. The result was strong enough to raise a serious mental-privacy debate — but it did not demonstrate remote or coercive mind reading. The researchers found that cooperation from the individual participant was required both to train and apply the decoder, and deliberate resistance disrupted decoding.

The appropriate response is neither ridicule nor panic. Current technology has important limits, but the direction of progress shows why safeguards are needed before extracting sensitive mental information becomes easier. Mental privacy is not a right we should begin protecting only after it has already been technically lost.

Neural activity is not a fixed digital code that can be read once and permanently stored. Electrodes can move, tissue reacts to implants, and neural patterns vary with fatigue, disease progression, learning, medication, and time. Calibration, adaptive algorithms, and long-term signal stability are therefore central to practical usefulness.

This is also why a result from one laboratory is not automatically a universal capability. A BCI is a human–signal–algorithm–device system, not a self-contained brain reader. If one link fails, the function on which a user may have come to rely can fail with it.

Surgery, biocompatibility, and long-term risk

An invasive BCI involves intervention in or around the nervous system. Risks can include bleeding, infection, inflammation, tissue injury, implantation complications, material degradation, and the need for removal or repeat surgery. Different approaches have different risk profiles; an endovascular system, for example, avoids open craniotomy but introduces vascular and antithrombotic requirements.

For a person who has lost speech or limb control, those risks may be proportionate to a major potential benefit. For a healthy person seeking faster input or a competitive advantage, the equation is different. When there is no disease or lost function, invasiveness does not become less serious simply because the goal is called an “upgrade.”

Neural data are biological data from which systems may infer intentions, responses, motor states, and in some contexts cognitive characteristics. Their special sensitivity does not come from every EEG trace revealing secret thoughts; it comes partly from the fact that inferential power can increase after the data have already been collected, as better models are developed.

That makes consent unusually difficult. A person may consent today to data being used for cursor control, while the same archive becomes useful tomorrow for an analysis that could not have been anticipated at the time. Protecting mental privacy therefore requires more than a conventional “I agree” checkbox.

A 2026 review of data protections for implantable BCIs identifies concrete gaps: ordinary de-identification may be insufficient, individual control rights can be weak, treatment consent can be conflated with data consent, secondary uses may lack adequate limits, and ownership can be underspecified. This is not an abstract issue. A BCI creates value from signals generated inside a person’s nervous system.

THY-REALITY therefore supports a strict principle: a therapeutic user should not lose practical sovereignty over neural data merely because the device is proprietary. Rights of access, portability, deletion where feasible, limits on secondary use, and a clear separation between medical function and commercial profiling should be foundational rather than post-scandal add-ons.

Cybersecurity becomes bodily and mental security

A security failure in an ordinary app may expose a password or photograph. In a neural interface, an attack can involve signals, decoding models, user identity, or — in systems that include stimulation and feedback loops — functional device behavior. A survey of neural-interface cybersecurity distinguishes risks at the data, permission, and model levels, including neural-data leakage and adversarial manipulation of algorithms.

There is no evidence that today’s clinical BCIs enable Hollywood-style “hacking of a human being.” That is exactly why architecture should be secured now rather than after wider deployment. When a digital system sits on the path between intention and action, cybersecurity is no longer merely an IT issue.

A classic BCI often decodes activity to control an external device. The broader neurotechnology landscape also includes stimulation and closed-loop systems that detect a state and trigger an intervention. Such systems can have major therapeutic value in neurological disease. They also make questions about who sets the target, threshold, and permitted intervention more important.

The categories should not be blurred: a BCI is not automatically a behavior-control device, and neurostimulation is not the same as mind reading. But when sensing and intervention are combined, demands for transparency, local control, an off-switch, and accountability become stronger. A system capable of influencing the nervous system should not become a black box the user is expected to trust blindly.

An implant is not merely a piece of metal or silicon. It may depend on a battery, external hardware, software, algorithms, data formats, service protocols, and a team capable of maintaining the system. A 2025 systematic review on neural-device explantation notes that long-term support, removal, and responsibility are less developed ethically than device innovation itself.

For a therapeutic user this is especially serious: if a BCI restores communication, loss of support is not equivalent to cancelling a phone subscription. Before implantation, it should be clear who guarantees service, for how long, who pays for removal, what happens if the company fails, and whether the user retains access to data and technical documentation. Borgification: When the Human Becomes Part of the Network will examine network dependency more broadly.

BCIs for healthy people: where treatment ends

Once BCIs move from severe disability toward proposals for improving healthy memory, attention, communication, or productivity, the burden of proof changes. A 2024 systematic scoping review of neuromodulation and BCIs for enhancement in healthy people found above all insufficient evidence about efficacy and safety, along with concerns about identity, justice, and socioeconomic effects.

THY-REALITY does not treat that path as self-evident progress. If a healthy person does not need an invasive system for ordinary cognitive function, there must be an exceptionally strong reason to make the brain physically and informationally dependent on outside infrastructure. A human being is not an unfinished machine waiting for a USB port.

Even if a future BCI were shown to enhance some ability, that would not create a moral duty to use it. The danger appears if employers, militaries, schools, insurers, or competitive markets begin to treat the unenhanced person as slower, less safe, or less employable. A formally optional technology can then become infrastructural coercion.

The right to cognitive and bodily integrity must therefore be practical: a person must be able to refuse an implant without losing basic opportunities for employment, education, insurance, or social participation. Freedom to “choose enhancement” without an equally strong freedom to remain unenhanced is not full freedom.

Children, workers, and people who do not bargain from equal power

For an adult patient with major medical need, informed consent can be built around a clear risk–benefit question. The situation is different for a child, an employee under pressure, a soldier in a hierarchy, or someone whose livelihood depends on compliance. A signature on a form does not by itself establish that the decision was truly free.

UNESCO’s 2025 global Recommendation on the Ethics of Neurotechnology therefore emphasizes dignity, autonomy, mental privacy, and caution about uses beyond medicine. For THY-REALITY the principle is straightforward: the closer a technology comes to thought and volition, the higher the threshold must be against coercion, hidden data capture, and commercial manipulation.

The FDA issued specific guidance for implanted BCIs in paralysis or amputation in 2021, showing that the field is no longer merely laboratory futurism. The OECD developed responsible-innovation principles for neurotechnology, and UNESCO adopted the first global Recommendation on the Ethics of Neurotechnology in November 2025. Across these frameworks, recurring concerns include safety, privacy, autonomy, accountability, and human rights.

A normative instrument is not the same as universally enforceable law. Regulation differs by country, consumer devices may fall under different regimes than medical implants, and technical development moves faster than legislation. Allowing dependency to be built first and rights to be defined later is the worst possible order.

Human sovereignty as the measure of progress

BCIs force a better question than “can we do it?”: does the technology increase a person’s real freedom, or transfer that freedom into a system on which the person becomes dependent? For someone with paralysis, restored communication can be an extraordinary increase in sovereignty. For a healthy person, unnecessary permanent integration can mean the opposite — a new biological, data, and contractual dependency.

This article therefore does not reject treatment or romanticize suffering in the name of “nature.” It rejects the assumption that healthy humans must be technologically connected in order to be fit for the future. Technology should remain a tool in human hands; the human being must not become a peripheral component of a technological system.

Before calling a BCI medical progress, consumer innovation, or human enhancement, ask nine questions: 1) what exact function does it restore or add; 2) what clinical evidence supports it; 3) what are the surgical and long-term risks; 4) what neural data are collected; 5) who controls them; 6) can the system function without a server or vendor; 7) how can it be disabled or removed; 8) is refusal genuinely penalty-free; 9) can the same benefit be achieved by a less invasive method.

Those questions separate rehabilitation from an ideology of upgrading. If technology gives a person back speech, movement, or independence, it deserves serious and fair evaluation. If it asks a healthy person to open the brain to a device, algorithm, and business model for the promise of greater efficiency, it is legitimate to ask not only what we might gain, but what we may be surrendering.